☰

Chao-Hung Lee - Publications

Affiliations: 
Pathology and Laboratory Medicine Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Parasitology Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Zhang C, Lei GS, Shao S, Jung HW, Durant PJ, Lee CH. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infection and Immunity. 80: 3634-41. PMID 22868498 DOI: 10.1128/Iai.00668-12  0.357
2011 Lasbury ME, Liao CP, Hage CA, Durant PJ, Tschang D, Wang SH, Zhang C, Lee CH. Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia. American Journal of Respiratory Cell and Molecular Biology. 44: 540-7. PMID 20558778 DOI: 10.1165/Rcmb.2009-0367Oc  0.558
2010 Cheng BH, Liu Y, Xuei X, Liao CP, Lu D, Lasbury ME, Durant PJ, Lee CH. Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages. Bmc Microbiology. 10: 103. PMID 20377877 DOI: 10.1186/1471-2180-10-103  0.595
2010 Zhang C, Wang SH, Liao CP, Shao S, Lasbury ME, Durant PJ, Lee CH. Downregulation of PU.1 leads to decreased expression of Dectin-1 in alveolar macrophages during Pneumocystis pneumonia. Infection and Immunity. 78: 1058-65. PMID 20065023 DOI: 10.1128/Iai.01141-09  0.559
2009 Liao CP, Phanstiel O, Lasbury ME, Zhang C, Shao S, Durant PJ, Cheng BH, Lee CH. Polyamine transport as a target for treatment of Pneumocystis pneumonia. Antimicrobial Agents and Chemotherapy. 53: 5259-64. PMID 19805570 DOI: 10.1128/Aac.00662-09  0.525
2009 Lasbury ME, Durant PJ, Liao CP, Lee CH. Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia. Infection and Immunity. 77: 3344-54. PMID 19487471 DOI: 10.1128/Iai.00299-09  0.559
2009 Liao CP, Lasbury ME, Wang SH, Zhang C, Durant PJ, Murakami Y, Matsufuji S, Lee CH. Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. The Journal of Biological Chemistry. 284: 8174-84. PMID 19158080 DOI: 10.1074/Jbc.M805787200  0.576
2008 Wang SH, Zhang C, Lasbury ME, Liao CP, Durant PJ, Tschang D, Lee CH. Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia. Microbes and Infection / Institut Pasteur. 10: 334-41. PMID 18400546 DOI: 10.1016/J.Micinf.2007.12.014  0.547
2006 Lasbury ME, Wang SH, Zhang C, Liao CP, Durant PJ, Tschang D, Lee CH. Caspase-9 as a target for Pneumocystis pneumonia therapy. The Journal of Eukaryotic Microbiology. 53: S138-9. PMID 17169033 DOI: 10.1111/J.1550-7408.2006.00205.X  0.464
2006 Lasbury ME, Durant PJ, Tschang D, Wang SH, Zhang C, Liao CP, Lee CH. Expression and activation of complement protein and alveolar damage during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S136-7. PMID 17169032 DOI: 10.1111/J.1550-7408.2006.00204.X  0.504
2006 Liao CP, Lasbury ME, Wang SH, Zhang C, Durant PJ, Tschang D, Lee CH. Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S134-5. PMID 17169031 DOI: 10.1111/J.1550-7408.2006.00203.X  0.607
2006 Zhang C, Wang SH, Liao CP, Lasbury ME, Durant PJ, Tschang D, Lee CH. Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages. The Journal of Eukaryotic Microbiology. 53: S132-3. PMID 17169030 DOI: 10.1111/J.1550-7408.2006.00202.X  0.572
2006 Lasbury ME, Ray CA, Durant PJ, Wang SH, Zhang C, Liao CP, Tschang D, Lee CH. Survival pathway signal transduction is reduced in alveolar macrophages during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S130-1. PMID 17169029 DOI: 10.1111/J.1550-7408.2006.00201.X  0.562
2006 Ray CA, Lasbury ME, Durant PJ, Wang SH, Zhang C, Liao CP, Tschang D, Lee CH. Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S127-9. PMID 17169028 DOI: 10.1111/J.1550-7408.2006.00200.X  0.526
2006 Lasbury ME, Durant PJ, Wang SH, Zhang C, Liao CP, Tschang D, Lee CH. GM-CSF expression in the lung during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S124-6. PMID 17169027 DOI: 10.1111/J.1550-7408.2006.00199.X  0.566
2006 Wang SH, Zhang C, Liao CP, Lasbury ME, Durant PJ, Tschang D, Lee CH. Syndecan-1 expression in the lung during Pneumocystis infection. The Journal of Eukaryotic Microbiology. 53: S122-3. PMID 17169026 DOI: 10.1111/J.1550-7408.2006.00198.X  0.527
2006 Lasbury ME, Durant PJ, Wang SH, Zhang C, Liao CP, Tschang D, Lee CH. Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 53: S119-21. PMID 17169024 DOI: 10.1111/J.1550-7408.2006.00197.X  0.486
2006 Lasbury ME, Durant PJ, Ray CA, Tschang D, Schwendener R, Lee CH. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia. Journal of Immunology (Baltimore, Md. : 1950). 176: 6443-53. PMID 16709801 DOI: 10.4049/Jimmunol.176.11.6443  0.396
2006 Zhang C, Wang SH, Lasbury ME, Tschang D, Liao CP, Durant PJ, Lee CH. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infection and Immunity. 74: 1857-64. PMID 16495560 DOI: 10.1128/Iai.74.3.1857-1864.2006  0.551
2003 Lee CH, Lasbury ME, Xuei X, Jerome RE, Edenberg HJ, Lu D, Durant PJ, Tschang D. Transcriptional changes in alveolar macrophages during Pneumocystis pneumonia. The Journal of Eukaryotic Microbiology. 50: 645. PMID 14736199 DOI: 10.1111/J.1550-7408.2003.Tb00666.X  0.334
2003 Lasbury ME, Durant PJ, Lee CH. Transtracheal inoculation of Pneumocystis carinii in immunocompetent animals. The Journal of Eukaryotic Microbiology. 50: 643-4. PMID 14736198 DOI: 10.1111/J.1550-7408.2003.Tb00665.X  0.366
2003 Lasbury ME, Lin PM, Tschang D, Durant PJ, Lee CH. Pneumocystis carinii factor responsible for reduced phagocytic activity in alveolar macrophages. The Journal of Eukaryotic Microbiology. 50: 641-2. PMID 14736197 DOI: 10.1111/J.1550-7408.2003.Tb00664.X  0.421
2003 Lasbury ME, Durant PJ, Lee CH. Inducible nitric oxide synthase expression in Pneumocystis carinii pneumonia. The Journal of Eukaryotic Microbiology. 50: 634-5. PMID 14736193 DOI: 10.1111/J.1550-7408.2003.Tb00660.X  0.321
2003 Lasbury ME, Durant PJ, Lee CH. Environmental stress and encystment of Pneumocystis carinii. The Journal of Eukaryotic Microbiology. 50: 632-3. PMID 14736192 DOI: 10.1111/J.1550-7408.2003.Tb00659.X  0.368
2003 Lasbury ME, Durant PJ, Lee CH. Decrease in alveolar macrophage number during Pneumocystis carinii infection. The Journal of Eukaryotic Microbiology. 50: 630-1. PMID 14736191 DOI: 10.1111/J.1550-7408.2003.Tb00658.X  0.432
2003 Lasbury ME, Tang X, Durant PJ, Lee CH. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infection and Immunity. 71: 4943-52. PMID 12933836 DOI: 10.1128/Iai.71.9.4943-4952.2003  0.446
2003 Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clinical and Diagnostic Laboratory Immunology. 10: 293-302. PMID 12626457 DOI: 10.1128/Cdli.10.2.293-302.2003  0.423
2001 Lasbury ME, Durant PJ, Lee CH. Bronchoalveolar lavage fluid from Pneumocystis carinii-infected rats inhibits phagocytosis in normal alveolar macrophages Journal of Eukaryotic Microbiology. 48. PMID 11906045 DOI: 10.1111/J.1550-7408.2001.Tb00502.X  0.384
2001 Lasbury ME, Durant PJ, Lee CH. Changes in alveolar macrophage number are early events in Pneumocystis carinii infection Journal of Eukaryotic Microbiology. 48. PMID 11906044 DOI: 10.1111/J.1550-7408.2001.Tb00501.X  0.336
2001 Lasbury ME, Tang X, Durant PJ, Lee CH. Effect of the transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts Journal of Eukaryotic Microbiology. 48. PMID 11906041 DOI: 10.1111/J.1550-7408.2001.Tb00499.X  0.361
1998 Bartlett MS, Angus WC, Shaw MM, Durant PJ, Lee C, Pascale JM, Smith JW. Antibody to Pneumocystis carinii Protects Rats and Mice from Developing Pneumonia Clinical and Vaccine Immunology. 5: 74-77. DOI: 10.1128/Cdli.5.1.74-77.1998  0.328
1997 Shaw MM, McChesney JD, Nanayakkara D, Dias LR, Lee CH, Durant PJ, Ball MD, Smith JW, Bartlett MS. Modified 8-aminoquinolines cure mouse Pneumocystis carinii infection. The Journal of Eukaryotic Microbiology. 44: 40S. PMID 9508428 DOI: 10.1111/J.1550-7408.1997.Tb05764.X  0.314
1997 Tang X, Bartlett MS, Smith JW, Lee CH. A single-tube nested PCR for Pneumocystis carinii f. sp. hominis. Journal of Clinical Microbiology. 35: 1597-9. PMID 9163492 DOI: 10.1128/Jcm.35.6.1597-1599.1997  0.305
1997 O'Gara MJ, Lee CH, Weinberg GA, Nott JM, Queener SF. IMP dehydrogenase from Pneumocystis carinii as a potential drug target. Antimicrobial Agents and Chemotherapy. 41: 40-8. PMID 8980752 DOI: 10.1128/Aac.41.1.40  0.31
1996 Bartlett MS, Current WL, Goheen MP, Boylan CJ, Lee CH, Shaw MM, Queener SF, Smith JW. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 40: 1811-6. PMID 8843286 DOI: 10.1128/Aac.40.8.1811  0.31
1996 Asnicar MA, Goheen M, Bartlett MS, Smith JW, Lee CH. Upregulation of host mitochondrial ATPase 6 gene in Pneumocystis carinii-infected rat lungs. The Journal of Eukaryotic Microbiology. 43: 38S. PMID 8822841 DOI: 10.1111/J.1550-7408.1996.Tb04974.X  0.339
1996 Lasbury ME, Brady S, McLaughlin G, Bartlett MS, Smith JW, Lee CH. Cloning of the S-adenosylhomocysteine hydrolase gene of Pneumocystis carinii. The Journal of Eukaryotic Microbiology. 43: 6S. PMID 8822814 DOI: 10.1111/J.1550-7408.1996.Tb04947.X  0.312
1994 Lu JJ, Bartlett MS, Shaw MM, Queener SF, Smith JW, Ortiz-Rivera M, Leibowitz MJ, Lee CH. Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. Journal of Clinical Microbiology. 32: 2904-12. PMID 7883876 DOI: 10.1128/Jcm.32.12.2904-2912.1994  0.303
1993 Lee CH, Bauer NL, Shaw MM, Durkin MM, Bartlett MS, Queener SF, Smith JW. Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. Journal of Clinical Microbiology. 31: 1659-62. PMID 8315014 DOI: 10.1128/Jcm.31.6.1659-1662.1993  0.321
1992 Durkin MM, Bartlett MS, Queener SF, Shaw MM, Lee CH, Smith JW. An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivo. Journal of Clinical Microbiology. 30: 3258-62. PMID 1452712 DOI: 10.1128/Jcm.30.12.3258-3262.1992  0.352
1986 Lee CH, Bolinger CD, Bartlett MS, Kohler RB, Wilde CE, Smith JW. Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells. Journal of Clinical Microbiology. 23: 505-8. PMID 3514660 DOI: 10.1128/Jcm.23.3.505-508.1986  0.345
Show low-probability matches.